NATCOPHARM — Natco Pharma Share News
0.000.00%
Last trade - 00:00- IN₹141.83bn
- IN₹120.26bn
- IN₹40.78bn
Brief: Natco Pharma Launches Pomalidomide Capsules In U.S. Market
Brief: Breckenridge Pharmaceutical Launches Pomalidomide Capsules
Brief: Natco Pharma To Launch Semaglutide In India In March 2026
Brief: Eris Lifesciences Announces Strategic Partnership With Natco Pharma For Semaglutide Launch In India
India's Natco Pharma jumps on approval for diabetes drug in India
Brief: Natco Pharma Says API Unit In Chennai Receives Establishment Inspection Report From U.S. FDA
Brief: Natco Pharma Dec-Quarter Consol Net Profit 1.52 Billion Rupees
Brief: Natco Pharma Receives Tentative Approval For Erdafitinib Tablets
Brief: NATCO Pharma Says NATCO Pharma Asia Buys 49% Of PT Natco Lotus Farma
India's Natco Pharma gains as expansion plans support earnings outlook
Brief: Natco Pharma Concludes US FDA Inspection At Chennai API Unit
Brief: Natco Pharma Sept-Quarter Consol Revenue From Operations 13.63 Billion Rupees
Brief: Natco Pharma Announces Launch Of Its Everolimus Tablets
Brief: Natco Pharma Updates On The Legal Proceedings On Risdiplam In India
India's Natco Pharma gains after court dismisses plea in Risdiplam launch case
Indian pharma stocks fall after Trump's new drug tariffs; mostly 'sentimental', say analysts (updated)
Brief: Natco Pharma Says Board Approves Evaluation Of Agro Business Demerger
Brief: Natco Pharma Says FDA Conducted Inspection At Natco Pharma In Kothur
India's Natco Pharma rises after US FDA closes inspection without urging action